• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    AptarGroup Inc. filed SEC Form 8-K: Financial Statements and Exhibits

    5/2/24 4:05:42 PM ET
    $ATR
    Plastic Products
    Industrials
    Get the next $ATR alert in real time by email
    false --12-31 0000896622 0000896622 2024-05-01 2024-05-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    May 1, 2024
    Date of Report (Date of earliest event reported)

     

    AptarGroup, Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware
    (State or other jurisdiction of
    incorporation)
      1-11846
    (Commission File Number)
      36-3853103
    (IRS Employer Identification No.)

     

    265 Exchange Drive, Suite 301, Crystal Lake, Illinois 60014

    (Address of principal executive offices)

     

    Registrant’s telephone number, including area code: 815-477-0424

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

      

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, $.01 par value   ATR   New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company   ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨

     

     

     

     

     

     

     

    Item 5.03.Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.

     

    On May 1, 2024, AptarGroup, Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the stockholders of the Company approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to reflect new Delaware law provisions regarding officer exculpation (the “Amendment”), as further described in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on March 22, 2024. The Amendment to the Certificate of Incorporation became effective upon the filing of the Certificate of Amendment to the Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware on May 1, 2024. The foregoing description of the Amendment is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.

     

    Item 5.07.Submission of Matters to a Vote of Security Holders.

     

    Set forth below are the final voting results for each of the proposals submitted to a vote of the stockholders at the Annual Meeting.

     

    Each of the three directors nominated for election was elected to serve until the Company’s 2027 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified. The voting results were as follows:

     

    Nominee   For   Against   Abstain   Broker Non-Votes  
    Sarah Glickman   54,633,297   1,780,170   37,404   3,404,617  
    Matt Trerotola   54,278,758   2,134,228   37,885   3,404,617  
    Ralf K. Wunderlich   55,071,340   1,242,855   136,676   3,404,617  

     

    Stockholders approved, on an advisory basis, the Company’s executive compensation. The voting results were as follows:

     

    For   Against   Abstain   Broker Non-Votes  
    54,941,844   1,450,088   58,939   3,404,617  

     

    Stockholders approved the amendment to the Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. The voting results were as follows:

     

    For   Against   Abstain   Broker Non-Votes  
    50,467,260   5,935,072   48,539   3,404,617  

     

    Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. The voting results were as follows:

     

    For   Against   Abstain   Broker Non-Votes  
    58,621,619   781,232   452,637   0  

     

     

     

     

    Item 9.01. Financial Statement and Exhibits.

     

    (d)Exhibits

     

    3.1 Certificate of Amendment to the Amended and Restated Certificate of Incorporation of AptarGroup, Inc., dated May 1, 2024.
       
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      AptarGroup, Inc.
       
    Date: May 2, 2024 By: /s/ Kimberly Y. Chainey
        Kimberly Y. Chainey
        Chief Legal Officer and Secretary

     

     

     

     

    Get the next $ATR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATR

    DatePrice TargetRatingAnalyst
    1/6/2026$133.00Overweight → Equal Weight
    Wells Fargo
    11/3/2025Outperform → Mkt Perform
    William Blair
    9/4/2025$220.00Overweight
    KeyBanc Capital Markets
    1/7/2025$200.00Outperform
    Raymond James
    1/6/2025$173.00Buy → Neutral
    BofA Securities
    10/14/2024$155.00 → $215.00Hold → Buy
    Jefferies
    4/29/2024Mkt Perform → Outperform
    William Blair
    1/3/2024$125.00 → $150.00Neutral → Outperform
    Robert W. Baird
    More analyst ratings

    $ATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aptar to Participate in Upcoming Investor Conferences

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that it will present at two upcoming investor conferences: The Bank of America Securities 2026 Global Agriculture and Materials Conference in Ft. Lauderdale, FL on Wednesday, February 25, 2026. Stephan Tanda, President and CEO, will present at 9:45 a.m. Eastern Standard Time. The Raymond James 2026 Institutional Investors Conference on Tuesday, March 3, 2026. Vanessa Kanu, Executive Vice President and CFO, will present at 1:05 p.m. Eastern Standard Time. A live audio webcast and presentation materials will be available in the "Investors"

    2/18/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Reports Fourth Quarter and Annual 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended December 31, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205227722/en/Photo: Aptar Fourth Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 14% and core sales increased 5%—all three segments delivered core sales growth Reporte

    2/5/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is February 25, 2026, to stockholders of record as of February 4, 2026. As previously announced, Aptar will hold a conference call on Friday, February 6, 2026, at 8:00 a.m. Central Time to discuss the Company's fourth quarter and year-end results for 2025. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. A replay of the conference call can also be accessed fo

    1/22/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AptarGroup downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded AptarGroup from Overweight to Equal Weight and set a new price target of $133.00

    1/6/26 8:44:42 AM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup downgraded by William Blair

    William Blair downgraded AptarGroup from Outperform to Mkt Perform

    11/3/25 9:08:28 AM ET
    $ATR
    Plastic Products
    Industrials

    KeyBanc Capital Markets initiated coverage on AptarGroup with a new price target

    KeyBanc Capital Markets initiated coverage of AptarGroup with a rating of Overweight and set a new price target of $220.00

    9/4/25 8:59:59 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by AptarGroup Inc.

    SCHEDULE 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/11/26 12:08:11 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form 10-K filed by AptarGroup Inc.

    10-K - APTARGROUP, INC. (0000896622) (Filer)

    2/6/26 11:57:37 AM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - APTARGROUP, INC. (0000896622) (Filer)

    2/5/26 5:01:05 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, Asia Gong Xiangwei covered exercise/tax liability with 291 shares, decreasing direct ownership by 3% to 9,794 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    2/25/26 2:07:32 PM ET
    $ATR
    Plastic Products
    Industrials

    Chief Human Resources Officer Vinczeller Shiela covered exercise/tax liability with 219 shares, decreasing direct ownership by 0.88% to 24,747 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    2/25/26 2:05:46 PM ET
    $ATR
    Plastic Products
    Industrials

    President and CEO Tanda Stephan B. covered exercise/tax liability with 1,321 shares, decreasing direct ownership by 0.65% to 202,678 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    2/25/26 2:03:42 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Financials

    Live finance-specific insights

    View All

    Aptar Reports Fourth Quarter and Annual 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended December 31, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205227722/en/Photo: Aptar Fourth Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 14% and core sales increased 5%—all three segments delivered core sales growth Reporte

    2/5/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is February 25, 2026, to stockholders of record as of February 4, 2026. As previously announced, Aptar will hold a conference call on Friday, February 6, 2026, at 8:00 a.m. Central Time to discuss the Company's fourth quarter and year-end results for 2025. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. A replay of the conference call can also be accessed fo

    1/22/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Announces 2026 Quarterly Conference Call Dates

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases. Quarterly Conference Calls   Press Release(1) Conference Call(2) 4th Quarter and Annual 2025 Results February 5, 2026 February 6, 2026, at 8:00 a.m. CT 1st Quarter 2026 Results April 30, 2026 May 1, 2026, at 8:00 a.m. CT 2nd Quarter 2026 Results July 30, 2026 July 31, 2026, at 8:00 a.m. CT 3rd Quarter 2026 Results

    1/7/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/13/24 4:58:57 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 3:08:10 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 11:53:37 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Leadership Updates

    Live Leadership Updates

    View All

    Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company

    Aptar Names Vanessa Kanu, A Finance Veteran with Over 25 Years of Experience, as Next CFO AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Bob Kuhn, Executive Vice President and Chief Financial Officer (CFO) since 2008, has decided to retire at the end of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725873916/en/(Left to right) Bob Kuhn, Executive Vice President and Chief Financial Officer since 2008, has decided to retire at the end of 2024; Vanessa Kanu will become Executive Vice President and CFO on January 1, 2025,

    7/25/24 5:20:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905451175/en/Sarah Glickman Joins Aptar's Board of Directors (Photo: Aptar) "We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah's extensive knowledge of all aspects of corporate finance coupled with her global operational experience, including in the pharmaceutical industry

    9/5/23 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Appoints Julie Xing to its Board of Directors

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that Julie Xing has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230220005172/en/Julie Xing Joins Aptar's Board of Directors (Photo: Aptar) With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie's leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. With her solid track record of business transformation in multiple g

    3/1/23 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials